BioRender 图标

CTLA-4 (monomer, short)

CTLA-4 (monomer, short) - Editable icon of a short CTLA-4 protein monomer with ligand binding domain head, bent linker and a cytosolic tail
[{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f82b/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f82b/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f82a/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f82a/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f829/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f829/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f828/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f828/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f827/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f827/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f826/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f826/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f825/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f825/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f824/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f824/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f823/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f823/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f822/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f822/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f821/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f821/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f820/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f820/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81f/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81f/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81e/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81e/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81d/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81d/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81c/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81c/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81b/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81b/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f81a/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f81a/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f819/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f819/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f818/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f818/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f817/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f817/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f816/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f816/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f815/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f815/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f814/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f814/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f813/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f813/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f812/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f812/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f811/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f811/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f810/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f810/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80f/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80f/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80e/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80e/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80d/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80d/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80c/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80c/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80b/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80b/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f80a/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f80a/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f809/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f809/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f808/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f808/6333119dd8c4400021f6f806.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6333120ad8c4400021f6f807/6333119dd8c4400021f6f806.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6333120ad8c4400021f6f807/6333119dd8c4400021f6f806.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
CTLA4,CTLA-4,CD152,cytotoxic t-lymphocyte associated 4,ALPS4,CELIAC3,GRD4,GSE,IDDM12,immune checkpoint,t-cell,T cell,APC,CD89,CD86,short,monomer,proj-shortreceptor-icons-22q1,CTLA4,CTLA-4
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

CTLA-4 (monomer, short) icon JPEG

CTLA-4 (monomer, short) icon PNG

CTLA-4 (monomer, short) icon SVG

CTLA-4 (monomer, short) icon GIF

BioRender 图标常见问题解答

How are scientists using the CTLA-4 (monomer, short) icon in their work?

BioRender users often use the CTLA-4 (monomer, short) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the CTLA-4 (monomer, short) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the CTLA-4 (monomer, short) icon customizable in BioRender?

Most icons in BioRender, including the CTLA-4 (monomer, short) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the CTLA-4 (monomer, short) icon for publication or presentations?

Yes, figures containing the CTLA-4 (monomer, short) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the CTLA-4 (monomer, short) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the CTLA-4 (monomer, short) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this CTLA-4 (monomer, short) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon